SEC Filing Document

Company: ERock, Inc.
Ticker: 
CIK: 2110029
Filing Type: DRS/A
Document Type: DRS/A
Date Filed: 2026-04-01
Accession Number: 0001193125-26-138217
Exchange: 
SIC Code: 3620
SIC Description: Electrical Industrial Apparatus
URL: https://www.sec.gov/Archives/edgar/data/2110029/000119312526138217/filename1.htm

Chunk 68 of 104
Word Count: 1495
Character Count: 9185

Document Content:

deals yielding gross margin of less than 20%. Mr. McAndrew’s employment may be terminated for Cause at any time, without Cause upon 90 days advance written notice, or upon written notice in the event of disability or upon death. If Mr. McAndrew’s employment is terminated without Cause prior to the end of the initial term, he will receive any earned sales commissions through the end of the 90-day notice period. The agreement also contains non-competition covenants covering the one-year period post-termination or until his termination date if he is terminated without Cause prior to the end of the initial term, in which case ER Management may elect to extend the non-compete period for one year subject to ER Management’s payment of his base salary through such extension period. ER Management also agreed to pay 100% of the premiums for Mr. McAndrew’s coverage under ER Management’s health and other insurance plans.

“Cause” for purposes of
Mr. McAndrew’s employment agreement generally means his: (i) willful misconduct which has been, or would reasonably be expected to be, materially injurious to ER Management and its affiliates, (ii) fraud, embezzlement or any
other act of dishonesty against ER Management or its affiliates, or a willful breach of a fiduciary duty to ER Management or its affiliates, (iii) conviction of, or plea of guilty or nolo contendere to a felony or any crime involving moral
turpitude, (iv) material breach of any agreement with or policy of ER Management or its affiliates, and such breach is not cured within 30 days of written notice, (v) abuse of any alcoholic, controlled or illegal substance or drug which
materially interferes the performance of his duties, or (vi) commitment of any act that damages the reputation of ER Management or its affiliates.

Outstanding Equity Awards at Fiscal Year-End

The following table presents information regarding the outstanding equity awards held by our NEOs as of December 31, 2025.

Stock Awards

Name Grant Date Number of shares or units of stock that have not vested (#) (1) Market value of shares of units of stock
that have not vested ($) (2)

John Carrington June 18, 2025 1,065	(3) $	387,544

November 26, 2025 22,084	(4) $	3,042,350

Corey Amthor (5) April 1, 2023 192 $	69,887

July 1, 2024 247 $	89,907

July 29, 2025 3,000 $	1,092,034

November 26, 2025 7,362 $	1,014,162

Ian Blakely (6) April 1, 2023 192 $	69,887

July 29, 2025 5,000 $	1,819,846

November 26, 2025 1,227 $	169,028

Paul Froutan (7) May 16, 2022 402 $	146,327

June 1, 2024 835 $	303,937

July 29, 2025 3,000 $	587,667

November 26, 2025 2,454 $	338,054

Thomas McAndrew — — —

(1)	Reflects outstanding unvested Compensatory Units held by the applicable NEO as of December 31, 2025.

(2)	The Compensatory Units are intended to qualify as “profits interests” for U.S. tax purposes.
They do not require the payment of an exercise price but are economically similar to stock appreciation rights because they have no value for tax purposes as of the grant date and will obtain value only as the underlying value of the security rises
above its grant date value, which is referred to as the “Threshold Amount.” The market value as of December 31, 2025 of such unvested Compensatory Units were calculated based on a third-party valuation of ER Holdings and the
applicable Threshold Amount of such Compensatory Units

Table of Contents

(3)	These Compensatory Units will vest in equal monthly installments through November 26, 2026 subject to the
NEO’s continued service through each vesting date.

(4)	These Compensatory Units will vest in equal monthly installments through November 26, 2028, subject to
the NEO’s continued service through each vesting date.

(5)	The Compensatory Units reported for Mr. Amthor will vest as reflected below subject to his continued
service through each vesting date.

Grant Date Vesting Schedule

April 1, 2023 144 units will vest upon this offering, a Company Sale (as defined below), or a Distribution Achievement (as defined below)
and the remaining unvested units will vest monthly at the end of each month through March of 2027.

July 1, 2024 150 units will vest upon this offering, a Company Sale, or a Distribution Achievement and the remaining unvested units will
vest monthly at the end of each month through May of 2028.

July 29, 2025 The unvested units will vest monthly on the monthly anniversary of the grant date through July 29, 2028.

November 26, 2025 The unvested units will vest monthly on the monthly anniversary of the grant date through November 26,

(6)	The Compensatory Units reported for Mr. Blakely will vest as reflected below subject to his continued
service through each vesting date.

Grant Date Vesting Schedule

April 1, 2023 144 units will vest upon this offering, a Company Sale, or a Distribution Achievement and the remaining unvested units will
vest monthly at the end of each month through March of 2027.

July 29, 2025 The unvested units will vest monthly on the monthly anniversary of the grant date through July 29, 2028.

November 26, 2025 The unvested units will vest monthly on the monthly anniversary of the grant date through November 26,

(7)	The Compensatory Units reported for Mr. Froutan will vest as reflected below subject to his continued
services through each vesting date.

Grant Date Vesting Schedule

May 16, 2022 The unvested units will vest monthly on the monthly anniversary of the grant date through May 16, 2026.

June 1, 2024 520 units will vest upon this offering, a Company Sale, or a Distribution Achievement and the remaining unvested units will
vest monthly at the end of each month through May of 2028.

July 29, 2025 The unvested units will vest monthly on the monthly anniversary of the grant date through July 29, 2028.

November 26, 2025 The unvested units will vest monthly on the monthly anniversary of the grant date through November 26,

Additional Narrative Disclosure

Retirement Benefits

Each of our NEOs are eligible to participate in our 401(k) plan, which is a broad-based,
tax-qualified defined contribution retirement plan in which all of our U.S. employees who meet the age and service

Table of Contents

requirements can participate. Under the 401(k) plan, we make matching contributions equal to a 100% match on up to 3% of employee contributions and a 50% match on the next 2% of employee
contributions, subject to certain limits under the Internal Revenue Code of 1986, as amended (the “Code”). We do not sponsor any non-qualified deferred compensation plans, supplemental retirement
plans, or defined benefit plans.

Potential Payments Upon Termination or Change in Control

Pursuant to their respective employment agreements, (i) Mr. Carrington is entitled to receive severance payments upon
a termination without Cause or resignation for Good Reason, and (ii) Mr. McAndrew is entitled to a notice period upon termination and certain payments following termination in the event ER Management elects to extend the non-compete period under his agreement, in each case, as described above under “Employment Agreements.”

In addition, ER Management maintains the Enchanted Rock Management, LLC Executive Severance Plan (the “Severance
Plan”) under which Messrs. Amthor, Blakely, and Froutan may receive severance benefits upon a termination of their employment by ER Management without Cause. Upon such a qualifying termination, subject to the NEO’s execution of a release
of claims, such NEO would receive (i) cash severance payments equal to 12 months of base salary for Mr. Amthor and six months of base salary for Messrs. Blakely and Froutan, payable on a monthly basis, (ii) any earned annual bonus for
the fiscal year prior to the year of termination, (iii) a pro-rated annual bonus for the year of termination based on actual performance of any performance metrics, and (iv) company-paid COBRA
premiums for continuation of group health benefits for 12 months for Mr. Amthor and six months for Messrs. Blakely and Froutan.

Under the Severance Plan, “Cause” is generally defined as the NEO’s (i) material breach of any written
policy or code of conduct applicable to the NEO, (ii) gross negligence or willful misconduct in connection with the performance of the NEO’s duties, or violation of any law applicable to the workplace, (iii) breach of fiduciary duty,
fraud, theft or embezzlement, (iv) commission, conviction or indictment of, or plea of nolo contendere to, any felony (or state law equivalent) or any crime involving moral turpitude, or (v) willful failure or refusal, other than due to
disability, to perform the NEO’s obligations pursuant to the Severance Plan, or to follow any lawful directive from the Board.

Compensatory
Units

As noted in the “Outstanding Equity Awards” table above, certain outstanding Compensatory Units
previously granted to Messrs. Amthor, Blakely, and Froutan vest 50% on a time-based schedule in equal monthly installments and 50% on the earlier to occur of a Company Sale, a Distribution Achievement or an IPO. This offering is not expected to
constitute a Company Sale or Distribution Achievement but will constitute an IPO for purposes of such grants.